BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6533207)

  • 1. [Immunohistological evaluation of the cancer associate antigen (TA-4) for pathoclinical management of the cervical malignancy].
    Kimura A; Shibata K; Hoshina M; Maruo T; Mochizuki M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2248-54. PubMed ID: 6533207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
    Göcze P; Vahrson H
    Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
    Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
    Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
    Oka K; Nakano T; Hoshi T
    Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
    Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma.
    Kato H; Morioka H; Aramaki S; Torigoe T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(1):51-6. PubMed ID: 533610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological studies on the extension of uterine cervical cancer].
    Shibata K; Iwasaki M; Mochizuki M
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):67-74. PubMed ID: 3611892
    [No Abstract]   [Full Text] [Related]  

  • 12. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
    Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
    Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
    Kato H; Nagaya T; Torigoe T
    Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the special tumor marker of cervical cancer of the uterus.
    Kato H
    Semin Surg Oncol; 1987; 3(1):55-63. PubMed ID: 3544141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix?
    Patsner B; Orr JW; Allmen T
    Obstet Gynecol; 1989 Nov; 74(5):786-8. PubMed ID: 2812656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 19. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
    Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
    Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.